Table of Content

1 Definition
1.1 Inclusion and Exclusion Criteria

2 Research Scope
2.1 Key Questions Answered in the Report:

3 Research Methodology
3.1 Cell-Based Assay Market: Research Methodology
3.2 Primary Data Sources
3.3 Secondary Data Sources
3.4 Market Estimation Model
3.5 Criteria for Company Profiling

4 Markets Overview
4.1 Market Introduction
4.1.1 Types of Cell-Based Assays
4.2 Current and Future State of Cell-Based Assays in Industries
4.3 Emerging Technologies and Applications in the Cell-Based Assay Market
4.4 Current Market Size and Growth Potential, $Billion, 2022-2032
4.5 COVID-19 Impact on Cell-Based Assay Market
4.5.1 Impact on Cell-Based Assay Companies

5 Industry Insights
5.1 Overview
5.2 Legal Requirements and Frameworks in Europe

6 Market Dynamics
6.1 Overview
6.2 Impact Analysis
6.2.1 Market Drivers
6.2.1.1 Increase in Demand for Cell-Based Assay in Drug Discovery and Development
6.2.1.2 Rise in Life Sciences Research Investments
6.2.1.3 Technological Advancements
6.2.2 Market Restraints
6.2.2.1 High Cost
6.2.2.2 Lack of Standardization
6.2.3 Market Opportunities
6.2.3.1 Increased Focus on Regenerative Medicine
6.2.3.2 Emergence of Novel Gene Editing Technologies

7 Competitive Landscape
7.1 Competitive Landscape Overview
7.1.1 Key Developments
7.1.2 Product Launch and Expansion Activities
7.1.3 Merger and Acquisition Activities
7.1.4 Synergistic Activities
7.1.5 License and Agreement Activities
7.2 Market Share Analysis (2022)
7.3 Growth-Share Analysis (2021-2022)
7.3.1 Growth-Share Analysis (by Company)

8 Europe
8.1 Overview
8.2 Europe
8.2.1 Germany
8.2.2 U.K.
8.2.3 France
8.2.4 Italy
8.2.5 Spain
8.2.6 Rest-of-Europe

9 Company Profiles
9.1 Overview
9.1.1 Merck KGaA
9.1.1.1 Company Overview
9.1.1.2 Role of Merck KGaA in the Cell-Based Assay Market
9.1.1.3 Major Product: Key Specifications
9.1.1.4 Key Competitors
9.1.1.5 Analyst Perspective
9.1.2 Lonza Group AG
9.1.2.1 Company Overview
9.1.2.2 Role of Lonza Group AG in the Cell-Based Assay Market
9.1.2.3 Major Product: Key Specifications
9.1.2.4 Key Competitors
9.1.2.5 Analyst Perspective
List of Tables
Table 1: Current and Future State of Cell-Based Assay in Industries
Table 2: Utilizing the Potential of Cell-Based Assays: Novel Instruments and Methodologies in 2020-2021
List of Figures
Figure 1: Impact Analysis of Drivers, Challenges, and Opportunities on the Cell-Based Assay Market
Figure 2: Cell-Based Assay Market (by Region), 2022
Figure 3: Cell-based Assay Market Methodology
Figure 4: Primary Research Methodology
Figure 5: Top-Down Approach (Segment-Wise Analysis)
Figure 6: Bottom-Up Approach (Segment-Wise Analysis)
Figure 7: Cellular Processes Utilized to Investigate the Impacts in Cell-Based Assays
Figure 8: Emerging Technologies in the Cell-Based Assay Market
Figure 9: Cell-Based Assay Market, $Billion, 2022-2032
Figure 10: Impact of COVID-19 on Cell-Based Assay Companies
Figure 11: Cell-Based Assay Market - Market Dynamics
Figure 12: Total U.S. Life Sciences Venture Capital Funding, $Billion, 2016-2021
Figure 13: Uses of Cell-based Assays in Regenerative Medicine
Figure 14: Share of Key Developments and Strategies, January 2020 to March 2023
Figure 15: Share of Product Launch and Expansion Activities (by Company), January 2020 to March 2023
Figure 16: Share of Merger and Acquisition Activities (by Company), January 2020 to March 2023
Figure 17: Share of Synergistic Activities (by Company), January 2020 to March 2023
Figure 18: Market Share Analysis for Cell-Based Assay Market, 2022
Figure 19: Growth-Share Analysis for Cell-Based Assay Market (by Company), 2021-2022
Figure 20: Cell-Based Assay Market Snapshot (by Region)
Figure 21: Cell-Based Assay Market (by Region), $Billion, 2022-2032\
Figure 22: Europe Cell-Based Assay Market, $Billion, 2022-2032
Figure 23: Europe: Market Dynamics
Figure 24: Europe Cell-Based Assay Market (by Country), $Billion, 2022-2032
Figure 25: Germany Cell-Based Assay Market, $Billion, 2022-2032
Figure 26: U.K. Cell-Based Assay Market, $Billion, 2022-2032
Figure 27: France Cell-Based Assay Market, $Billion, 2022-2032
Figure 28: Italy Cell-Based Assay Market, $Billion, 2022-2032
Figure 29: Spain Cell-Based Assay Market, $Billion, 2022-2032
Figure 30: Rest-of-Europe Cell-Based Assay Market, $Billion, 2022-2032
Figure 31: Total Number of Companies Profiled
Figure 32: Merck KGaA: Product Portfolio
Figure 33: Lonza Group AG: Product Portfolio